Switch to:
GlaxoSmithKline PLC (NYSE:GSK)
Cash from Financing
$-11,960 Mil (TTM As of Mar. 2014)

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2014, GlaxoSmithKline PLC paid $35 Mil more to buy back shares than it received from issuing new shares. It spent $1,497 Mil paying down its debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent $1,524 Mil paying cash dividends to shareholders. It spent $1,280 Mil on other financial activities. In all, GlaxoSmithKline PLC spent $4,337 Mil on financial activities for the three months ended in Mar. 2014.


Definition

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

GlaxoSmithKline PLC's Cash from Financing for the fiscal year that ended in Dec. 2013 is calculated as:

Cash from Financing(A: Dec. 2013 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=-1588.1383855+67.5453047776+0+-6062.6029654+-2751.23558484
=-10,334

GlaxoSmithKline PLC's Cash from Financing for the quarter that ended in Mar. 2014 is

Cash from Financing(Q: Mar. 2014 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=-35.175879397+-1497.48743719+0+-1524.2881072+-1279.7319933
=-4,337

GlaxoSmithKline PLC Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2014 was -3183.61153263 (Jun. 2013 ) + -1776.16747182 (Sep. 2013 ) + -2663.92092257 (Dec. 2013 ) + -4336.68341709 (Mar. 2014 ) = $-11,960 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

Cash from financing contains five items:

1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

GlaxoSmithKline PLC's net issuance of stock for the three months ended in Mar. 2014 was $-35 Mil. GlaxoSmithKline PLC paid $35 Mil more to buy back shares than it received from issuing new shares.

2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

GlaxoSmithKline PLC's net issuance of debt for the three months ended in Mar. 2014 was $-1,497 Mil. GlaxoSmithKline PLC spent $1,497 Mil paying down its debt.

3. Net Issuance of Preferred:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

GlaxoSmithKline PLC's net issuance of preferred for the three months ended in Mar. 2014 was $0 Mil. GlaxoSmithKline PLC paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

4. Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

GlaxoSmithKline PLC's cash flow for dividends for the three months ended in Mar. 2014 was $-1,524 Mil. GlaxoSmithKline PLC spent $1,524 Mil paying cash dividends to shareholders.

5. Other Financing:
Money spent or earned by company from other financial activities.

GlaxoSmithKline PLC's other financing for the three months ended in Mar. 2014 was $-1,280 Mil. GlaxoSmithKline PLC spent $1,280 Mil on other financial activities.


Related Terms

Cash Flow from Operations, Cash Flow from Investing, Net Issuance of Stock, Net Issuance of Debt, Dividends, Net Issuance of Preferred


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

GlaxoSmithKline PLC Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Net Issuance of Stock -1,756-1,202-1,726-6,341-5,280-299-3,000-3,380-1,588
Net Issuance of Debt 1,73133-1,5159,5953,4911,952-2,106-25,77368
Net Issuance of Preferred 0000000000
Dividends -4,654-4,230-5,092-5,503-4,347-4,851-5,241-5,652-6,093-6,063
Other Financing -1,722243-1,060-1,181-957-1,580-1,539-1,023-1,653-2,751
Cash from Financing -6,401-5,156-9,394-3,430-7,092-4,481-8,787-9,677-5,353-10,334

GlaxoSmithKline PLC Quarterly Data

Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14
Net Issuance of Stock -335-222-1,145-1,105-88849-21-763-837-35
Net Issuance of Debt -8-293,8258151,075233-926638170-1,497
Net Issuance of Preferred 0000000000
Dividends -1,261-1,355-2,254-1,383-1,058-1,332-1,921-1,469-1,041-1,524
Other Financing -402-387-254-277-732-1,178-316-182-956-1,280
Cash from Financing -2,006-1,994172-1,949-1,602-2,228-3,184-1,776-2,664-4,337
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide